BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire
*MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE)* — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual..
*MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE)* — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual..
*BIOPROCESSING REVENUES INCREASE 42% FIRST MULTI-PARAMETER SENSOR ("MPS") PRODUCTS SHIPPED IN APRIL*
Investor Call to be..
· *Achieved net revenue of $8.9 million for the three months ended March 31, 2024*
· *Adjusted EBITDA*^*1** loss of..